Allergy Diagnostics Market Size & Share Analysis - Growth Trends & Forecasts (2023 - 2028)

Allergy Skin Test Market Analysis

The Allergy Diagnostics Market is expected to witness a CAGR of 11.3% during the forecast period (2022 - 2027).

The COVID-19 pandemic has posed serious challenges to healthcare systems and has largely been controlled by drastically cutting down in- and outpatient services for diseases and implementing infection prevention and control measures. The lockdown all over the globe has affected the supply chain of diagnostic kits and other diagnostic supplies. The pandemic has significantly impacted the growth of the allergic diagnostics market due to the pandemic situation and restrictions, healthcare settings such as hospitals and diagnostic centers were temporary. For instance, according to an article published by the Clinical and Translational Allergy, in September 2021, titled ‘Recent advances and developments in COVID-19 in the context of allergic diseases, it has been observed that the United States and United Kingdom (UK) had increased prevalence of COVID-19 in patients with asthma. In addition, as per the same source, the Asia Pacific Association of Allergy Asthma and Clinical Immunology (APAAACI) surveyed its 14 member countries that found that the COVID-19 pandemic had an elevated prevalence of allergy illnesses, such as ocular and airway allergies with extended use of surgical masks and eye protection, skin allergy due to prolonged use of gloves, among healthcare personnel. Additionally, in an article published by the Clinical and Translational Allergy, in January 2022, titled ‘Allergic patients during the COVID-19 pandemic—Clinical practical considerations: An European Academy of Allergy and Clinical Immunology survey’, it has been observed that the pandemic had an impact on medical professionals who treated allergic patients in terms of diagnostic, management, and treatment techniques, including allergen immunotherapy (AIT) for food, insect venom, and respiratory allergies. Moreover, most allergy/immunology care was delayed or postponed, or handled through virtual care. For patients with asthma of a certain severity, there was a limited provision for face-to-face visits under critical conditions. Such factors have impacted the market growth during the pandemic.

Certain factors that are propelling the market growth are increasing incidences of allergic diseases and environmental pollution.

The rising incidences of allergic diseases such as hives, atopic dermatitis, allergic conjunctivitis, and others are expected to increase the market growth. For instance, according to an article published by StatPearls, in August 2021, titled 'Eczema', it has been observed that the lifetime prevalence of eczema in children is between 15-30% and 2-10% in adults. In addition, as per the same source, about 50% of the patients with severe atopic dermatitis are likely to develop asthma and 75% are likely to develop allergic rhinitis. Additionally, according to an article published by Annals of Allergy, Asthma, and Immunology, in July 2021, titled ‘Rhinitis prevalence and association with atopic dermatitis, as per the meta-analysis the pooled prevalence of rhinitis was 40.5% in patients with atopic dermatitis and 18% in patients without atopic dermatitis, in 2020. In addition, as per the same source, the pooled prevalence of rhinitis and asthma was 14.2% in patients with atopic dermatitis.

In addition, food allergy is a growing health concern, with increasing prevalence in both developed and developing countries. For instance, according to the 2022 statistics published by the Food Allergy Research and Education, about 2.8 million Americans are expected to have egg allergy, 2.5 million wheat allergy, in 2020, Thus, the rising burden of various allergic diseases among the population increases the demand for early detection and diagnosis of the allergen which is expected to increase the demand for effective diagnostic tests or systems, which in turn is anticipated to propel the market growth.

Furthermore, the increasing focus of the companies on research and development activities to develop novel diagnostic products, tests, or kits to cater to high unmet medical needs is highly impacting the market’s growth. For instance, in November 2020, Omega Diagnostics received approval from the China National Medical Products Administration (NMPA) for Omega's food detective test in China. Also, in August 2020, HYCOR Biomedical and Changsha Haike Biotechnology Co., Ltd., registered its ALLEOS 2000 allergy testing system in China Hunan Medical Products Administration (HMPA).

However, the lack of awareness about allergic diseases and the affordability of allergy diagnostics are likely to impede the market growth over the forecast period.

Allergy Skin Test Market Trends

This section covers the major market trends shaping the Allergy Diagnostics Market according to our research experts:

Inhaled Allergens Segment Expects to Register a High CAGR in the Allergy Diagnostics Market Over the Forecast Period

Allergy Skin Test Industry Segmentation

As per the scope of the report, allergy diagnostics are processes performed in clinical conditions in which a harmless external agent is suspected to have a pathological effect on a human being, thus causing discomfort. The diagnostic procedure for allergies depends on the type of allergens and the mode of transmission. The allergy diagnostics market is segmented by allergens (inhaled allergens, food allergens, and other allergens), products (instruments, consumables, and luminometers), end users (diagnostic laboratories, hospitals, and other end users) and geography (North America, Europe, Asia-Pacific, Middle East and Africa, and South America). The market report also covers the estimated market sizes and trends for 17 different countries across major regions globally. The report offers the value (in USD million) for the above segments.